Carlos A. Twardowschy
Curitiba, PR, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson disease.
Journal: JHEP reports : innovation in hepatology
Published: September 22, 2025
Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.
Journal: JHEP reports : innovation in hepatology
Published: September 22, 2025
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets.
Journal: JHEP reports : innovation in hepatology
Published: October 30, 2023
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: May 04, 2022
Comparison of screening tests in the evaluation of cognitive status of patients with epilepsy.
Journal: Dementia & neuropsychologia
Published: April 28, 2021
Presence of generalized periodic discharges and hospital mortality.
Journal: Arquivos de neuro-psiquiatria
Published: January 21, 2020
CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment.
Journal: Pharmacogenomics and personalized medicine
Published: April 11, 2018
The role of CYP2C9 polymorphisms in phenytoin-related cerebellar atrophy.
Journal: Seizure
Published: July 19, 2012
Chorea due to gabapentin monotherapy in a not encephalopatic patient.
Journal: Arquivos de neuro-psiquiatria
Published: April 09, 2008
Showing 1-10 of 10
Last Updated: 09/26/2026